药品:专业
Major 阿根廷公司 producing pharmaceuticals
全球制药巨头大规模开发并分销处方药。专利到期、新药管线获批以及医疗卫生相关立法，是推动相关股票交易活跃度和行业流动性的主要因素。市场数据显示，Pfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs目前是交易量最高的资产，而AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1在24小时回报率榜单中名列前茅。下表列出了这些股票的关键技术指标与基本面指标。
商品代码 | 总市值 | 价格 | 涨跌 % | 成交量 | 相对成交量 | P/E | 摊薄每股收益 净利率，TTM | 每股收益缓慢增长 TTM同比 | 股息收益率 % 净利率，TTM | 板块 | 分析师评级 |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 ShsDR | 2,064.96 T ARS | 41,000 ARS | 0.00% | 7.57 K | 0.39 | 52.42 | 782.10 ARS | +87.54% | 0.27% | 健康科技 | 尚无评分 |
| LLY.CIEli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs DR | 2,064.96 T ARS | 41,300.00 ARS | −3.14% | 2.44 K | 1.63 | 52.81 | 782.10 ARS | +87.54% | 0.27% | 健康科技 | 尚无评分 |
| LLYDEli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs DR | 2,064.96 T ARS | 25.85 USD | −1.52% | 882 | 0.19 | 50.46 | 782.10 ARS | +69.67% | 0.27% | 健康科技 | 尚无评分 |
| LLYCEli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs DR | 2,064.96 T ARS | 24.35 USD | −1.50% | 15 | 0.04 | 47.53 | 782.10 ARS | +69.67% | 0.27% | 健康科技 | 尚无评分 |
 JNJ.CIJohnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 ShsDR | 1,029.7 T ARS | 30,180.00 ARS | −2.33% | 1.4 K | 1.81 | 48.30 | 624.89 ARS | −19.54% | 1.07% | 健康科技 | 尚无评分 |
| JNJJohnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs DR | 1,029.7 T ARS | 30,500 ARS | +0.79% | 5.76 K | 0.36 | 48.81 | 624.89 ARS | −19.54% | 1.07% | 健康科技 | 尚无评分 |
| JNJDJohnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs DR | 1,029.7 T ARS | 19.40 USD | −0.61% | 931 | 0.48 | 47.40 | 624.89 ARS | −27.20% | 1.07% | 健康科技 | 尚无评分 |
| JNJCJohnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs DR | 1,029.7 T ARS | 18.32 USD | +2.63% | 13 | 0.22 | 44.76 | 624.89 ARS | −27.20% | 1.07% | 健康科技 | 尚无评分 |
 ABBV.CIAbbVie, Inc. Shs Cert Deposito Arg Repr 0.1DR | 806.73 T ARS | 48,240.00 ARS | −1.11% | 213 | 2.37 | 5.72 | 8,434.44 ARS | +471.49% | 1.36% | 健康科技 | 尚无评分 |
| ABBVAbbVie, Inc. Shs Cert Deposito Arg Repr 0.1 DR | 806.73 T ARS | 48,760 ARS | +1.46% | 932 | 0.44 | 5.78 | 8,434.44 ARS | +471.49% | 1.36% | 健康科技 | 尚无评分 |
| ABBVCAbbVie, Inc. Shs Cert Deposito Arg Repr 0.1 DR | 806.73 T ARS | 29.97 USD | +11.95% | 1 | 0.03 | 5.42 | 8,434.44 ARS | +417.02% | 1.36% | 健康科技 | 尚无评分 |
| ABBVDAbbVie, Inc. Shs Cert Deposito Arg Repr 0.1 DR | 806.73 T ARS | 30.90 USD | +0.32% | 238 | 2.04 | 5.59 | 8,434.44 ARS | +417.02% | 1.36% | 健康科技 | 尚无评分 |
 MRK.CIMerck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 ShDR | 574.25 T ARS | 49,860.00 ARS | +0.32% | 99 | 1.05 | 157.45 | 316.68 ARS | −81.79% | 1.28% | 健康科技 | 尚无评分 |
| MRKMerck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh DR | 574.25 T ARS | 48,100 ARS | −1.68% | 1.2 K | 0.41 | 151.89 | 316.68 ARS | −81.79% | 1.28% | 健康科技 | 尚无评分 |
| MRKCMerck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh DR | 574.25 T ARS | 29.71 USD | +5.17% | 2 | 0.26 | 143.23 | 316.68 ARS | −83.52% | 1.28% | 健康科技 | 尚无评分 |
| MRKDMerck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh DR | 574.25 T ARS | 31.21 USD | −0.92% | 188 | 1.15 | 150.46 | 316.68 ARS | −83.52% | 1.28% | 健康科技 | 尚无评分 |
 NVSNovartis AG ADR Cert Deposito Arg Repr 0.25 ADRsDR | 465.44 T ARS | 67,675 ARS | +0.07% | 51 | 0.06 | 8.93 | 7,578.33 ARS | −29.48% | 2.76% | 健康科技 | 尚无评分 |
| NVS.CINovartis AG ADR Cert Deposito Arg Repr 0.25 ADRs DR | 465.44 T ARS | 67,975.00 ARS | −1.24% | 39 | 1.96 | 8.97 | 7,578.33 ARS | −29.48% | 2.76% | 健康科技 | 尚无评分 |
| NVSDNovartis AG ADR Cert Deposito Arg Repr 0.25 ADRs DR | 465.44 T ARS | 43.78 USD | −0.39% | 2 | 0.07 | 8.82 | 7,578.33 ARS | −36.20% | 2.76% | 健康科技 | 尚无评分 |
 AZNAstraZeneca PLC ADRDR | 453.35 T ARS | 77,725 ARS | −0.73% | 161 | 0.10 | 35.50 | 2,189.33 ARS | +58.82% | 1.30% | 健康科技 | 尚无评分 |
| AZN.CIAstraZeneca PLC ADR DR | 453.35 T ARS | 78,200.00 ARS | −0.57% | 104 | 2.24 | 35.72 | 2,189.33 ARS | +58.82% | 1.30% | 健康科技 | 尚无评分 |
| AZNDAstraZeneca PLC ADR DR | 453.35 T ARS | 50.2 USD | −0.79% | 16 | 0.20 | 35.01 | 2,189.33 ARS | +43.68% | 1.30% | 健康科技 | 尚无评分 |
| AZNCAstraZeneca PLC ADR DR | 453.35 T ARS | 42.88 USD | −1.38% | 2 | 0.33 | 29.90 | 2,189.33 ARS | +43.68% | 1.30% | 健康科技 | 尚无评分 |
 NVONovo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-BDR | 293.16 T ARS | 9,585 ARS | −0.83% | 6.83 K | 0.48 | 1.63 | 5,880.69 ARS | +16.59% | 4.10% | 健康科技 | 尚无评分 |
| NVO.CINovo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B DR | 293.16 T ARS | 9,530.00 ARS | −6.84% | 369 | 1.03 | 1.62 | 5,880.69 ARS | +16.59% | 4.10% | 健康科技 | 尚无评分 |
| NVODNovo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B DR | 293.16 T ARS | 6.18 USD | +1.64% | 119 | 0.08 | 1.60 | 5,880.69 ARS | +5.48% | 4.10% | 健康科技 | 尚无评分 |
| NVOCNovo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B DR | 293.16 T ARS | 5.89 USD | +0.86% | 155 | 0.47 | 1.53 | 5,880.69 ARS | +5.48% | 4.10% | 健康科技 | 尚无评分 |
 PFEPfizer Inc Shs Cert Deposito Arg Repr 0.25 ShsDR | 271.67 T ARS | 12,260 ARS | +0.16% | 13.56 K | 0.13 | 47.50 | 258.13 ARS | −48.97% | 3.30% | 健康科技 | 尚无评分 |
| PFE.CIPfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs DR | 271.67 T ARS | 12,560.00 ARS | −1.88% | 2.29 K | 1.49 | 48.66 | 258.13 ARS | −48.97% | 3.30% | 健康科技 | 尚无评分 |
| PFECPfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs DR | 271.67 T ARS | 7.68 USD | +1.59% | 12 | 0.03 | 45.42 | 258.13 ARS | −53.83% | 3.30% | 健康科技 | 尚无评分 |
| PFEDPfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs DR | 271.67 T ARS | 7.80 USD | 0.00% | 793 | 0.12 | 46.13 | 258.13 ARS | −53.83% | 3.30% | 健康科技 | 尚无评分 |
 VRTXVertex Pharmaceuticals Incorporated Shs Cert Deposito Arg Repr 0.00990099 ShsDR | 215.48 T ARS | 9,020 ARS | +1.18% | 11.63 K | 3.18 | 0.00 | 2,252,619.76 ARS | +36.84% | 0.00% | 健康科技 | 尚无评分 |
| VRTX.CIVertex Pharmaceuticals Incorporated Shs Cert Deposito Arg Repr 0.00990099 Shs DR | 215.48 T ARS | 9,050.00 ARS | 0.00% | 12 | 0.07 | 0.00 | 2,252,619.76 ARS | +36.84% | 0.00% | 健康科技 | 尚无评分 |
| VRTXDVertex Pharmaceuticals Incorporated Shs Cert Deposito Arg Repr 0.00990099 Shs DR | 215.48 T ARS | 5.82 USD | −0.68% | 4.46 K | 19.02 | 0.00 | 2,252,619.76 ARS | +23.80% | 0.00% | 健康科技 | 尚无评分 |
 BMYBristol-Myers Squibb Company Shs Cert Deposito Arg Repr 0.333333 ShDR | 203.11 T ARS | 34,120 ARS | −3.18% | 358 | 0.55 | 15.79 | 2,160.37 ARS | +86.32% | 2.35% | 健康科技 | 尚无评分 |
| BMY.CIBristol-Myers Squibb Company Shs Cert Deposito Arg Repr 0.333333 Sh DR | 203.11 T ARS | 34,740.00 ARS | −1.31% | 123 | 2.05 | 16.08 | 2,160.37 ARS | +86.32% | 2.35% | 健康科技 | 尚无评分 |
| BMYDBristol-Myers Squibb Company Shs Cert Deposito Arg Repr 0.333333 Sh DR | 203.11 T ARS | 22.40 USD | +0.40% | 2 | 0.03 | 15.83 | 2,160.37 ARS | +68.56% | 2.35% | 健康科技 | 尚无评分 |
 GSK.CIGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsDR | 157.93 T ARS | 21,370.00 ARS | +4.91% | 130 | 2.26 | 20.57 | 1,039.13 ARS | +0.52% | 2.73% | 健康科技 | 尚无评分 |
| GSKGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs DR | 157.93 T ARS | 20,990 ARS | −0.76% | 63 | 0.06 | 20.20 | 1,039.13 ARS | +0.52% | 2.73% | 健康科技 | 尚无评分 |
| GSKCGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs DR | 157.93 T ARS | 12.37 USD | +5.91% | 17 | — | 18.17 | 1,039.13 ARS | −9.06% | 2.73% | 健康科技 | 尚无评分 |
| GSKDGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs DR | 157.93 T ARS | 13.59 USD | −0.88% | 1 | 0.04 | 19.97 | 1,039.13 ARS | −9.06% | 2.73% | 健康科技 | 尚无评分 |
 BAYNBayer AG ADR Cert Deposito Arg Repr 0.333333 ShsDR | 92.61 T ARS | 31,000 ARS | +4.17% | 6 | 0.12 | — | −962.50 ARS | +18.88% | 0.13% | 健康科技 | 尚无评分 |
 BIIBBiogen Inc Shs Cert Deposito Arg Repr 1/13 ShDR | 58.23 T ARS | 31,980 ARS | +2.76% | 1.41 K | 1.01 | 126.42 | 252.96 ARS | −74.19% | 0.00% | 健康科技 | 尚无评分 |
| BIIB.CIBiogen Inc Shs Cert Deposito Arg Repr 1/13 Sh DR | 58.23 T ARS | 31,380.00 ARS | −4.39% | 69 | 1.10 | 124.05 | 252.96 ARS | −74.19% | 0.00% | 健康科技 | 尚无评分 |
| BIIBDBiogen Inc Shs Cert Deposito Arg Repr 1/13 Sh DR | 58.23 T ARS | 20.79 USD | +1.46% | 11 | 0.17 | 125.47 | 252.96 ARS | −76.65% | 0.00% | 健康科技 | 尚无评分 |
 RICH.CILaboratorios Richmond SACIF Class B | 105.78 B ARS | 1,295.000 ARS | +2.78% | 1.07 K | 2.43 | 9.07 | 142.73 ARS | −19.05% | 2.49% | 健康科技 | 尚无评分 |
| RICHLaboratorios Richmond SACIF Class B | 105.78 B ARS | 1,395 ARS | +7.31% | 3.52 K | 1.01 | 9.77 | 142.73 ARS | −19.05% | 2.49% | 健康科技 | 尚无评分 |
 ROSEInstituto Rosenbusch SA Class B | 5.96 B ARS | 138.0 ARS | +0.73% | 500 | 0.06 | — | −10.22 ARS | +86.77% | 0.00% | 健康科技 | 尚无评分 |
| ROSE.CIInstituto Rosenbusch SA Class B | 5.96 B ARS | 130.0 ARS | −12.75% | 600 | 0.35 | — | −10.22 ARS | +86.77% | 0.00% | 健康科技 | 尚无评分 |